![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
|
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
554kB | |
![[img]](http://edoc.mdc-berlin.de/style/images/fileicons/application_msword.png) |
MS Word (Supplemental Material)
254kB |
| Item Type: | Letter |
|---|---|
| Title: | Genotype and intensive pretreatment influence outcome of acute myeloid leukemia patients treated with venetoclax in combination with hypomethylating agents or low-dose cytarabine: "real world" data from germany |
| Creators Name: | Braitsch, K. and Schmalbrock, L.K. and Jung, P. and Bumeder, I. and Kiewe, P. and Hecker, J.S. and Verbeek, M. and Westermann, J. and Bullinger, L. and Keller, U. and Bassermann, F. and Krönke, J. and Götze, K.S. and Rieger, K. |
| Source: | HemaSphere |
| ISSN: | 2572-9241 |
| Publisher: | Wolters Kluwer |
| Volume: | 6 |
| Number: | 9 |
| Page Range: | e759 |
| Date: | September 2022 |
| Official Publication: | https://doi.org/10.1097/HS9.0000000000000759 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
Download Statistics
Download Statistics
